Tyme Technologies (NASDAQ: TYME)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-09 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Tyme Technologies (NASDAQ: TYME) through any online brokerage.
Other companies in Tyme Technologies’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Connect Biopharma Hldgs (NASDAQ:CNTB), Evaxion Biotech (NASDAQ:EVAX), Infinity Pharmaceuticals (NASDAQ:INFI) and vTv Therapeutics (NASDAQ:VTVT).
The latest price target for Tyme Technologies (NASDAQ: TYME) was reported by Canaccord Genuity on Thursday, January 4, 2018. The analyst firm set a price target for 10.00 expecting TYME to rise to within 12 months (a possible 3323.49% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Tyme Technologies (NASDAQ: TYME) is $0.2921 last updated July 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Tyme Technologies.
Tyme Technologies’s Q1 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Tyme Technologies.
Tyme Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.